Navigation Links
FDA: Byetta Label Revised to Include Safety Information on Possible Kidney Problems
Date:11/2/2009

SILVER SPRING, Md., Nov. 2 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today acted on new safety information about possible kidney function problems, including kidney failure, in patients taking Byetta (exenatide), a drug used to treat Type 2 diabetes.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)

From April 2005 through October 2008, the FDA received 78 reports of problems with kidney function in patients using Byetta. Some cases occurred in patients with pre-existing kidney disease or in patients with one or more risk factors for developing kidney problems.

Nearly 7 million prescriptions for Byetta were dispensed between April 2005 and September 2008. The 78 cases represent a small percentage of the total number of patients using the drug to control blood sugar (glucose) levels.

The most common side effects associated with Byetta include nausea, vomiting, and diarrhea. These side effects may have contributed to the development of altered kidney function. Kidney malfunction can result in a build-up of waste products in the blood, leading to serious illness or life-threatening conditions.

"Health care professionals and patients taking Byetta should pay close attention to any signs or symptoms of kidney problems," said Amy Egan, M.D. M.P.H., of the Division of Metabolism and Endocrinology Products at the FDA's Center for Drug Evaluation and Research. "Patients also should be aware that problems with kidney function could lead to changes in urine color, frequency of urination or the amount of urine, unexplained swelling of the hands or feet, fatigue, changes in appetite or digestion, or dull ache in mid to lower back."

Patients who experience any of these symptoms should immediately discuss them with their health care professional.

To help health care professionals and pat
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
2. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
3. Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label
4. Proteolix Initiates Multicenter Open-label Study of the Safety and Activity of Carfilzomib in Subjects With Relapsed Solid Tumors
5. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
6. Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia
7. FDA Updates Label for AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years
8. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
9. VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
10. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
11. Schering-Plough Reports Long-Term Vicriviroc Data From Phase II Open-Label Extension Study in Treatment-Experienced HIV-Infected Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... NEW BRUNSWICK, N.J., Dec. 17 The ... opened the 2010 call for nominations. The $100,000 ... transformational contributions towards the improvement of human health. ... and will be accepted until February 15, ... independent selection committee of the world,s top scientists, ...
(Date:12/17/2009)... LITTLE FALLS, N.J., Dec. 17 CANTEL ... today that its Board of Directors intends to pay, ... $0.05 per outstanding share, or $0.10 per share annually, ... first cash dividend of $0.05 per share of outstanding ... to shareholders of record at the close of business ...
(Date:12/17/2009)... Reportlinker.com announces that a ... in its catalogue: ,, Negative ... and Market Forecasts to 2016 ... Negative Pressure Wound Therapy (NPWT) Pipeline ... ,, Summary ,, "Negative ...
Breaking Medicine Technology:Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research 2Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research 3Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research 4Cantel Medical Authorizes Semiannual Dividend 2Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 2Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 3Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 4Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 5Reportlinker Adds Negative Pressure Wound Therapy (NPWT) Pipeline Technology and Market Forecasts to 2016 6Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institutes 25th Anniversary 62194 1Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institutes 25th Anniversary 62194 2Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institutes 25th Anniversary 62194 3Why Some Vaccines May Require A Booster 62192 1Why Some Vaccines May Require A Booster 62192 2Why Some Vaccines May Require A Booster 62192 3North Carolina Based Cromoz Inc Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad India 14986 1North Carolina Based Cromoz Inc Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad India 14986 2
... 18, 2007 /PRNewswire/ -- Micell,Technologies announced today ... use of its supercritical fluid (SCF) surface ... Society for,Biomaterials 2007 Annual Meeting, April 19-21 ... use of Micell and PNNL's, 2006 R&D,100 ...
... for Cancer Research Annual,Meeting, SAN DIEGO, April ... biopharmaceutical company developing patient-specific,active immunotherapies for the ... study showing enhanced activity from insect-cell,derived idiotype ... Company's,Id/KLH immunotherapy product candidate FavId(R) for B-cell,non-Hodgkin's ...
Other Medicine Technology:Micell Technologies Presents Data on Novel Drug-Eluting Stents 2Micell Technologies Presents Data on Novel Drug-Eluting Stents 3Favrille Announces Results From Study Showing Enhanced Activity,From Insect Cell-Derived Immunotherapy for Lymphoma 2Favrille Announces Results From Study Showing Enhanced Activity,From Insect Cell-Derived Immunotherapy for Lymphoma 3Favrille Announces Results From Study Showing Enhanced Activity,From Insect Cell-Derived Immunotherapy for Lymphoma 4
(Date:12/17/2009)... It’s a common scenario. A pregnant woman, who has carefully examined ... in a birth plan – realizes that her healthcare provider is ... birth plan does not match her provider’s practice style. , ... ... a common scenario. A pregnant woman, who has carefully examined her ...
(Date:12/17/2009)... Omnicell, Inc ., (Nasdaq: OMCL ) ... acute healthcare facilities, today announced that CoxHealth, ... in Springfield, Missouri, has chosen Omnicell as its ... solutions. ,, "Omnicell,s patient-specific approach to supply and ... the nurses, access to, distribution and tracking of ...
(Date:12/17/2009)... Urges "Comprehensive Respect for Life" in Majority Leader,s ... ,, WASHINGTON, Dec. 17 Americans ... sent a letter today to Senate Majority Leader ... - the Majority Leader,s revisions to a bill ... letter urges Senator Reid to include "specific language ...
(Date:12/17/2009)... stations -- and adding to obesity epidemic, study says , , ... shopping for a new sofa, don,t despair: 22 percent of ... new report finds. , In fact, the sale of high-calorie ... most segments of the retail market, say the authors of ... Journal of Public Health . The easy availability of ...
(Date:12/17/2009)... lull in the outbreak is a good time to ... 17 (HealthDay News) -- As the current wave of ... on Thursday urged that everyone get vaccinated in case ... shortages of the H1N1 flu vaccine have eased, it,s ... and Human Services Secretary Kathleen Sebelius said during a ...
Breaking Medicine News(10 mins):Health News:Who Should Deliver Your Baby? New Tool Helps Expectant Parents Choose Their Health Care Provider 2Health News:Who Should Deliver Your Baby? New Tool Helps Expectant Parents Choose Their Health Care Provider 3Health News:CoxHealth Chooses Omnicell Solutions for Medication and Supply Management 2Health News:CoxHealth Chooses Omnicell Solutions for Medication and Supply Management 3Health News:CoxHealth Chooses Omnicell Solutions for Medication and Supply Management 4Health News:Pro-Life Leader Sends Urgent Letter to Senator Reid 2Health News:Wide Array of Stores Now Sell High-Calorie Snacks 2Health News:Swine Flu Wanes, But Future Uncertain 2
... 30 Today at the Radiological Society of,North ... announced,that it has expanded its Synapse Managed Services ... The company has also established a,partnership with Evolved ... RIS and off site archiving to their customers. ...
... linked to hardening of the arteries , , SUNDAY, Nov. 30 ... brought on by last summer,s spike in gas prices may ... emissions are among a long list of risk factors for ... and consistent body of data that links particulate air pollution ...
... A new method of characterizing breast lesions found ... of benign tumors with the benefits of reduced pain ... paper that will be presented today (Sunday, Nov. 30) ... North America (RSNA)., Wendy DeMartini, M.D., and colleagues in ...
... 29 Football fans may see an,unconventional anti-tobacco display at ... tailgating under a tent, rooting for their teams, grilling,tossing a ... that the tailgaters are skeletons. The message to fans is,"We ... (Photo: http://www.newscom.com/cgi-bin/prnh/20081129/CLSA002 ...
... WrinkleBest.com has released the selection of the Best Wrinkle Cream ... review site bases its reviews both on formalized research and ... The results are in, and the winner of the 2008 ... system is The Complete Rejuvenation System by Dermajuv. ...
... aren,t catering to those with fewer resources , , FRIDAY, Nov. ... 20 times more likely to donate a liver or kidney ... , The national study by Harvard University researchers found ... health insurance at the time of hospitalization. , In contrast, ...
Other Medicine News:Health News:Fujifilm Sees Significant Growth of Managed Services Business 2Health News:Fujifilm Sees Significant Growth of Managed Services Business 3Health News:Heavy Traffic Can Be Heartbreaking 2Health News:Heavy Traffic Can Be Heartbreaking 3Health News:New statistical model could help reduce breast-lesion biopsies 2Health News:Sudden Death Hits Stadiums Across Florida 2Health News: Wrinkle Cream Reviews Site Reveals a Winner for 2008's Best Wrinkle Creams : Wrinkle Cream reviewssite, WrinkleBest.com has released the Editor's Choice for Best Wrinkle Cream of 2008 2Health News: Wrinkle Cream Reviews Site Reveals a Winner for 2008's Best Wrinkle Creams : Wrinkle Cream reviewssite, WrinkleBest.com has released the Editor's Choice for Best Wrinkle Cream of 2008 3Health News:Uninsured Likely Organ Donors, But Not Recipients 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: